115 related articles for article (PubMed ID: 23070988)
21. Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site.
Torrent M; Nogués MV; Boix E
J Mol Recognit; 2011; 24(1):90-100. PubMed ID: 20213669
[TBL] [Abstract][Full Text] [Related]
22. Binding of interferon gamma by glycosaminoglycans: a strategy for localization and/or inhibition of its activity.
Fernandez-Botran R; Yan J; Justus DE
Cytokine; 1999 May; 11(5):313-25. PubMed ID: 10328871
[TBL] [Abstract][Full Text] [Related]
23. Identification of the Glycosaminoglycan Binding Site of Interleukin-10 by NMR Spectroscopy.
Künze G; Köhling S; Vogel A; Rademann J; Huster D
J Biol Chem; 2016 Feb; 291(6):3100-13. PubMed ID: 26677224
[TBL] [Abstract][Full Text] [Related]
24. Receptor-binding conformation of the "ELR" motif of IL-8: X-ray structure of the L5C/H33C variant at 2.35 A resolution.
Gerber N; Lowman H; Artis DR; Eigenbrot C
Proteins; 2000 Mar; 38(4):361-7. PubMed ID: 10707023
[TBL] [Abstract][Full Text] [Related]
25. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
[TBL] [Abstract][Full Text] [Related]
26. Computational Analysis of Solvent Inclusion in Docking Studies of Protein-Glycosaminoglycan Systems.
Samsonov SA
Methods Mol Biol; 2018; 1762():445-454. PubMed ID: 29594785
[TBL] [Abstract][Full Text] [Related]
27. Modulation of Abeta42 fibrillogenesis by glycosaminoglycan structure.
Valle-Delgado JJ; Alfonso-Prieto M; de Groot NS; Ventura S; Samitier J; Rovira C; Fernàndez-Busquets X
FASEB J; 2010 Nov; 24(11):4250-61. PubMed ID: 20585030
[TBL] [Abstract][Full Text] [Related]
28. Coarse-grained model of glycosaminoglycans.
Samsonov SA; Bichmann L; Pisabarro MT
J Chem Inf Model; 2015 Jan; 55(1):114-24. PubMed ID: 25490039
[TBL] [Abstract][Full Text] [Related]
29. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins.
Hileman RE; Fromm JR; Weiler JM; Linhardt RJ
Bioessays; 1998 Feb; 20(2):156-67. PubMed ID: 9631661
[TBL] [Abstract][Full Text] [Related]
30. Defining protein-protein interactions using site-directed spin-labeling: the binding of protein kinase C substrates to calmodulin.
Qin Z; Wertz SL; Jacob J; Savino Y; Cafiso DS
Biochemistry; 1996 Oct; 35(41):13272-6. PubMed ID: 8873591
[TBL] [Abstract][Full Text] [Related]
31. Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix.
Allain F; Vanpouille C; Carpentier M; Slomianny MC; Durieux S; Spik G
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2714-9. PubMed ID: 11867726
[TBL] [Abstract][Full Text] [Related]
32. Glycosaminoglycan (GAG) binding surfaces for characterizing GAG-protein interactions.
Robinson DE; Buttle DJ; Short RD; McArthur SL; Steele DA; Whittle JD
Biomaterials; 2012 Feb; 33(4):1007-16. PubMed ID: 22079008
[TBL] [Abstract][Full Text] [Related]
33. Mutational analysis and NMR spectroscopy of quail cysteine and glycine-rich protein CRP2 reveal an intrinsic segmental flexibility of LIM domains.
Kloiber K; Weiskirchen R; Kräutler B; Bister K; Konrat R
J Mol Biol; 1999 Oct; 292(4):893-908. PubMed ID: 10525413
[TBL] [Abstract][Full Text] [Related]
34. Role of the C-terminus in the activity, conformation, and stability of interleukin-6.
Ward LD; Hammacher A; Zhang JG; Weinstock J; Yasukawa K; Morton CJ; Norton RS; Simpson RJ
Protein Sci; 1993 Sep; 2(9):1472-81. PubMed ID: 8401231
[TBL] [Abstract][Full Text] [Related]
35. Investigation of the structure of regulatory proteins interacting with glycosaminoglycans by combining NMR spectroscopy and molecular modeling - the beginning of a wonderful friendship.
Künze G; Huster D; Samsonov SA
Biol Chem; 2021 Oct; 402(11):1337-1355. PubMed ID: 33882203
[TBL] [Abstract][Full Text] [Related]
36. Structure and dynamics of Mycobacterium tuberculosis truncated hemoglobin N: insights from NMR spectroscopy and molecular dynamics simulations.
Savard PY; Daigle R; Morin S; Sebilo A; Meindre F; Lagüe P; Guertin M; Gagné SM
Biochemistry; 2011 Dec; 50(51):11121-30. PubMed ID: 21999759
[TBL] [Abstract][Full Text] [Related]
37. GAG positioning on IL-1RI; A mechanism regulated by dual effect of glycosylation.
Azimzadeh Irani M; Ejtehadi MR
Glycobiology; 2019 Oct; 29(11):803-812. PubMed ID: 31317192
[TBL] [Abstract][Full Text] [Related]
38. Platelet endothelial cell adhesion molecule 1 (PECAM-1) and its interactions with glycosaminoglycans: 1. Molecular modeling studies.
Gandhi NS; Coombe DR; Mancera RL
Biochemistry; 2008 Apr; 47(17):4851-62. PubMed ID: 18393439
[TBL] [Abstract][Full Text] [Related]
39. Dimerization and Crowding in the Binding of Interleukin 8 to Dendritic Glycosaminoglycans as Artificial Proteoglycans.
Dürig JN; Schulze C; Bosse M; Penk A; Huster D; Keller S; Rademann J
Chemistry; 2024 Mar; 30(13):e202302758. PubMed ID: 38010268
[TBL] [Abstract][Full Text] [Related]
40. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V.
Friedrich MV; Göhring W; Mörgelin M; Brancaccio A; David G; Timpl R
J Mol Biol; 1999 Nov; 294(1):259-70. PubMed ID: 10556044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
